These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8549309

  • 1. In vitro and in vivo antibacterial activities of broad spectrum quinolones against clinical bacterial isolates.
    Matsumoto T, Tateda K, Ishii Y, Ohno A, Miyazaki S, Yamaguchi K.
    Drugs; 1995; 49 Suppl 2():219-21. PubMed ID: 8549309
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G, Pinsi G, Pirali F, Colombrita D, Foresti I, Peroni L, Turano A.
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Major advances in antibacterial quinolone therapy.
    Neu HC.
    Adv Pharmacol; 1994; 29A():227-62. PubMed ID: 7826861
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Quinolones. Gyrase inhibitors].
    Höffler D.
    Internist (Berl); 1994 May; 35(5):484-9. PubMed ID: 8021119
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of quinolone use on antimicrobial susceptibility patterns over a 5-year period.
    Segreti J, Connelly R.
    Drugs; 1995 May; 49 Suppl 2():185-7. PubMed ID: 8549297
    [No Abstract] [Full Text] [Related]

  • 16. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C.
    Annu Rev Microbiol; 1989 May; 43():601-27. PubMed ID: 2679364
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity and clinical efficacy of ciprofloxacin in otorhinolaryngeal infections.
    Speciale A, Blandino G, Caccamo F, Serra A.
    Drugs; 1995 May; 49 Suppl 2():403-5. PubMed ID: 8549378
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.